Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Retina > Eye examinations are important in patients with CKD
  • Retina

Eye examinations are important in patients with CKD

Kerri Fitzgerald
kidneys

A pooled analysis of more than 51,000 individuals indicated that chronic kidney disease (CKD) and compromised kidney function are significantly associated with late age-related macular degeneration (AMD).

The cross-sectional Asian Eye Epidemiology Consortium is a network of population-based Asian studies. This assessment included 51,253 patients (mean age, 54.1 years) from 10 studies. The following classification systems were used to define AMD:

  • Wisconsin Age-Related Maculopathy Grading System
  • International Age-Related Maculopathy Epidemiological Study Group Classification
  • Beckman Clinical Classification

CKD, defined as an estimated glomerular filtration rate (eGFR) of <60 mL/min/1.73 m2, was detected in 9.9% of patients in the cohort (n=5,079).

Early AMD was detected in 9.0% of patients, and late AMD was found in 0.71%. The researchers adjusted for:

  • Age
  • Sex
  • Hypertension
  • Diabetes
  • Body mass index
  • Smoking status
  • Cholesterol
  • Study groups

Individuals with CKD had greater odds of late AMD (odds ratio [OR], 1.46; 95% CI, 1.11-1.98; P=.008); poor kidney function was also associated with late AMD (OR, 1.12; 95% CI, 1.05-1.19; P=.001).

However, CKD and eGFR were not significantly associated with early AMD (P≥.149).

The researchers indicated that the connection between CKD and AMD may be due to shared influencing factors like susceptibility genes such as complement factor H and apolipoprotein E.

The study is limited by its inclusion of only Asian individuals, and the study’s findings should be confirmed in other ethnic populations, the authors noted.

“This finding further underscores the importance of ocular examinations in patients with CKD,” the authors concluded.

Reference

Xue CC, Sim R, Chee ML, et al. Is kidney function associated with age-related macular degeneration? Findings from the Asian Eye Epidemiology Consortium. Ophthalmology. 2024;131(6):692-699. doi:10.1016/j.ophtha.2023.12.030

Share

Related Content

  • Retina

Biosimilar aflibercept-ayyh demonstrates favorable real-world safety and efficacy

  • Retina

Switching to aflibercept 8 mg improved anatomical outcomes in previously treated nAMD

Neovascular Age-related Macular Degeneration: Emerging Therapies With an EYE On Treatment Frequency
  • Retina

Treat-and-extend aflibercept 8 mg improves outcomes in nAMD over 1 year

  • Retina

Intravitreal therapy in nAMD linked to lower depression and anxiety risk

  • Retina

Alternative aflibercept regimens maintained efficacy in wet AMD

  • Retina

Nanoscope Therapeutics is working on the potential first-ever optogenetic therapy for retinal diseases

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon